Page last updated: 2024-08-24

lisofylline and Acute Respiratory Distress Syndrome

lisofylline has been researched along with Acute Respiratory Distress Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, HS; Kaplan, LJ; Park, PK1
Arroliga, AC; Komara, JJ; Wiedemann, HP1
Abraham, E; Bianco, JA; Bursten, SL; Federighi, DA; Harris, WE; Moore, EE; Moore, FA; Parsons, P; Repine, JE; Singer, JW1
Berry, GJ; Bursten, S; Hasegawa, N; Nakayama, M; Oka, Y; Raffin, TA; Rice, G1
Lynch, RE1

Reviews

2 review(s) available for lisofylline and Acute Respiratory Distress Syndrome

ArticleYear
Reviewing the studies of the National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network: outcomes and clinical findings.
    Current problems in surgery, 2013, Volume: 50, Issue:10

    Topics: Acute Lung Injury; Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Bronchodilator Agents; Dietary Supplements; Enteral Nutrition; Fluid Therapy; Glucocorticoids; Humans; Pentoxifylline; Respiration, Artificial; Respiratory Distress Syndrome; Tidal Volume; Treatment Outcome

2013
Emerging systemic pharmacologic approaches in acute respiratory distress syndrome.
    Respiratory care clinics of North America, 2003, Volume: 9, Issue:4

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antioxidants; Atrial Natriuretic Factor; Humans; Ketoconazole; Pentoxifylline; Protein C; Recombinant Proteins; Respiratory Distress Syndrome

2003

Trials

2 trial(s) available for lisofylline and Acute Respiratory Distress Syndrome

ArticleYear
An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome.
    Critical care medicine, 1996, Volume: 24, Issue:7

    Topics: Adult; Double-Blind Method; Fatty Acids, Nonesterified; Fatty Acids, Unsaturated; Female; Humans; Male; Middle Aged; Pentoxifylline; Prospective Studies; Respiratory Distress Syndrome; Sepsis; Single-Blind Method; Wounds and Injuries; Xanthines

1996
Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome.
    Critical care medicine, 2002, Volume: 30, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Fatty Acids, Nonesterified; Humans; Infusions, Intravenous; Lung Diseases; Pentoxifylline; Prospective Studies; Respiratory Distress Syndrome

2002

Other Studies

2 other study(ies) available for lisofylline and Acute Respiratory Distress Syndrome

ArticleYear
The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs.
    American journal of respiratory and critical care medicine, 1997, Volume: 155, Issue:3

    Topics: Adjuvants, Immunologic; Animals; Disease Models, Animal; Female; Hemodynamics; Lung; Male; Pentoxifylline; Phosphatidic Acids; Pseudomonas Infections; Respiratory Distress Syndrome; Shock, Septic; Swine; Swine, Miniature; Time Factors

1997
Lisofylline: anti-acute respiratory distress syndrome or just anti-inflammatory?
    Critical care medicine, 2002, Volume: 30, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Lung Diseases; Pentoxifylline; Respiratory Distress Syndrome

2002